A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Celgene
- Links
- BMS Clinical Trial Information BMS Clinical Trial Patient Recruiting
- ID
- NCT03464097
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 485 study participants
- Last Updated